Austrian researchers are developing a cancer “vaccine” strategy for use in pediatric cancers. In a three-year pilot study carried out at St. Anna’s Children’s Hospital in Vienna, 20 children with advanced cancer underwent treatment with the new approach. Results were promising enough to prompt a larger study. In the study, doctors first removed the patients’ tumours by surgery.
They then cultured individual patients’ dendritic cells and exposed them to tumour cells, prompting them to display tumour antigens. After a quality check, the “vaccine” was administered to each child by injection over a four-and-a-half month period.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!